The global biomarkers market is projected to grow to $112.1b by 2031, from $67.95b in 2026, due to expanding use in drug ...
Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...